The global Influenza Vaccine market was valued at 319.82 Million USD in 2020 and will grow with a CAGR of 7.06% from 2020 to 2027, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
Influenza vaccines, also known as flu shots or flu jabs, are vaccines that protect against infection by Influenza viruses. A new version of the vaccine is developed twice a year, as the Influenza virus rapidly changes.
By Market Verdors:
AstraZeneca
CSL
GlaxoSmithKline
Sanofi
Altimmune
BionVax
FluGen
FOLIA BIOTECH
Genentech

By Types:
Trivalent
Quadrivalent

By Applications:
Adults
Pediatrics

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Influenza Vaccine Market Size Analysis from 2022 to 2027
1.5.1 Global Influenza Vaccine Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Influenza Vaccine Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Influenza Vaccine Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Influenza Vaccine Industry Impact
Chapter 2 Global Influenza Vaccine Competition by Types, Applications, and Top Regions and Countries
2.1 Global Influenza Vaccine (Volume and Value) by Type
2.1.1 Global Influenza Vaccine Consumption and Market Share by Type (2016-2021)
2.1.2 Global Influenza Vaccine Revenue and Market Share by Type (2016-2021)
2.2 Global Influenza Vaccine (Volume and Value) by Application
2.2.1 Global Influenza Vaccine Consumption and Market Share by Application (2016-2021)
2.2.2 Global Influenza Vaccine Revenue and Market Share by Application (2016-2021)
2.3 Global Influenza Vaccine (Volume and Value) by Regions
2.3.1 Global Influenza Vaccine Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Influenza Vaccine Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Influenza Vaccine Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Influenza Vaccine Consumption by Regions (2016-2021)
4.2 North America Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
4.10 South America Influenza Vaccine Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Influenza Vaccine Market Analysis
5.1 North America Influenza Vaccine Consumption and Value Analysis
5.1.1 North America Influenza Vaccine Market Under COVID-19
5.2 North America Influenza Vaccine Consumption Volume by Types
5.3 North America Influenza Vaccine Consumption Structure by Application
5.4 North America Influenza Vaccine Consumption by Top Countries
5.4.1 United States Influenza Vaccine Consumption Volume from 2016 to 2021
5.4.2 Canada Influenza Vaccine Consumption Volume from 2016 to 2021
5.4.3 Mexico Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 6 East Asia Influenza Vaccine Market Analysis
6.1 East Asia Influenza Vaccine Consumption and Value Analysis
6.1.1 East Asia Influenza Vaccine Market Under COVID-19
6.2 East Asia Influenza Vaccine Consumption Volume by Types
6.3 East Asia Influenza Vaccine Consumption Structure by Application
6.4 East Asia Influenza Vaccine Consumption by Top Countries
6.4.1 China Influenza Vaccine Consumption Volume from 2016 to 2021
6.4.2 Japan Influenza Vaccine Consumption Volume from 2016 to 2021
6.4.3 South Korea Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 7 Europe Influenza Vaccine Market Analysis
7.1 Europe Influenza Vaccine Consumption and Value Analysis
7.1.1 Europe Influenza Vaccine Market Under COVID-19
7.2 Europe Influenza Vaccine Consumption Volume by Types
7.3 Europe Influenza Vaccine Consumption Structure by Application
7.4 Europe Influenza Vaccine Consumption by Top Countries
7.4.1 Germany Influenza Vaccine Consumption Volume from 2016 to 2021
7.4.2 UK Influenza Vaccine Consumption Volume from 2016 to 2021
7.4.3 France Influenza Vaccine Consumption Volume from 2016 to 2021
7.4.4 Italy Influenza Vaccine Consumption Volume from 2016 to 2021
7.4.5 Russia Influenza Vaccine Consumption Volume from 2016 to 2021
7.4.6 Spain Influenza Vaccine Consumption Volume from 2016 to 2021
7.4.7 Netherlands Influenza Vaccine Consumption Volume from 2016 to 2021
7.4.8 Switzerland Influenza Vaccine Consumption Volume from 2016 to 2021
7.4.9 Poland Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 8 South Asia Influenza Vaccine Market Analysis
8.1 South Asia Influenza Vaccine Consumption and Value Analysis
8.1.1 South Asia Influenza Vaccine Market Under COVID-19
8.2 South Asia Influenza Vaccine Consumption Volume by Types
8.3 South Asia Influenza Vaccine Consumption Structure by Application
8.4 South Asia Influenza Vaccine Consumption by Top Countries
8.4.1 India Influenza Vaccine Consumption Volume from 2016 to 2021
8.4.2 Pakistan Influenza Vaccine Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Influenza Vaccine Market Analysis
9.1 Southeast Asia Influenza Vaccine Consumption and Value Analysis
9.1.1 Southeast Asia Influenza Vaccine Market Under COVID-19
9.2 Southeast Asia Influenza Vaccine Consumption Volume by Types
9.3 Southeast Asia Influenza Vaccine Consumption Structure by Application
9.4 Southeast Asia Influenza Vaccine Consumption by Top Countries
9.4.1 Indonesia Influenza Vaccine Consumption Volume from 2016 to 2021
9.4.2 Thailand Influenza Vaccine Consumption Volume from 2016 to 2021
9.4.3 Singapore Influenza Vaccine Consumption Volume from 2016 to 2021
9.4.4 Malaysia Influenza Vaccine Consumption Volume from 2016 to 2021
9.4.5 Philippines Influenza Vaccine Consumption Volume from 2016 to 2021
9.4.6 Vietnam Influenza Vaccine Consumption Volume from 2016 to 2021
9.4.7 Myanmar Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 10 Middle East Influenza Vaccine Market Analysis
10.1 Middle East Influenza Vaccine Consumption and Value Analysis
10.1.1 Middle East Influenza Vaccine Market Under COVID-19
10.2 Middle East Influenza Vaccine Consumption Volume by Types
10.3 Middle East Influenza Vaccine Consumption Structure by Application
10.4 Middle East Influenza Vaccine Consumption by Top Countries
10.4.1 Turkey Influenza Vaccine Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Influenza Vaccine Consumption Volume from 2016 to 2021
10.4.3 Iran Influenza Vaccine Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Influenza Vaccine Consumption Volume from 2016 to 2021
10.4.5 Israel Influenza Vaccine Consumption Volume from 2016 to 2021
10.4.6 Iraq Influenza Vaccine Consumption Volume from 2016 to 2021
10.4.7 Qatar Influenza Vaccine Consumption Volume from 2016 to 2021
10.4.8 Kuwait Influenza Vaccine Consumption Volume from 2016 to 2021
10.4.9 Oman Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 11 Africa Influenza Vaccine Market Analysis
11.1 Africa Influenza Vaccine Consumption and Value Analysis
11.1.1 Africa Influenza Vaccine Market Under COVID-19
11.2 Africa Influenza Vaccine Consumption Volume by Types
11.3 Africa Influenza Vaccine Consumption Structure by Application
11.4 Africa Influenza Vaccine Consumption by Top Countries
11.4.1 Nigeria Influenza Vaccine Consumption Volume from 2016 to 2021
11.4.2 South Africa Influenza Vaccine Consumption Volume from 2016 to 2021
11.4.3 Egypt Influenza Vaccine Consumption Volume from 2016 to 2021
11.4.4 Algeria Influenza Vaccine Consumption Volume from 2016 to 2021
11.4.5 Morocco Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 12 Oceania Influenza Vaccine Market Analysis
12.1 Oceania Influenza Vaccine Consumption and Value Analysis
12.2 Oceania Influenza Vaccine Consumption Volume by Types
12.3 Oceania Influenza Vaccine Consumption Structure by Application
12.4 Oceania Influenza Vaccine Consumption by Top Countries
12.4.1 Australia Influenza Vaccine Consumption Volume from 2016 to 2021
12.4.2 New Zealand Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 13 South America Influenza Vaccine Market Analysis
13.1 South America Influenza Vaccine Consumption and Value Analysis
13.1.1 South America Influenza Vaccine Market Under COVID-19
13.2 South America Influenza Vaccine Consumption Volume by Types
13.3 South America Influenza Vaccine Consumption Structure by Application
13.4 South America Influenza Vaccine Consumption Volume by Major Countries
13.4.1 Brazil Influenza Vaccine Consumption Volume from 2016 to 2021
13.4.2 Argentina Influenza Vaccine Consumption Volume from 2016 to 2021
13.4.3 Columbia Influenza Vaccine Consumption Volume from 2016 to 2021
13.4.4 Chile Influenza Vaccine Consumption Volume from 2016 to 2021
13.4.5 Venezuela Influenza Vaccine Consumption Volume from 2016 to 2021
13.4.6 Peru Influenza Vaccine Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Influenza Vaccine Consumption Volume from 2016 to 2021
13.4.8 Ecuador Influenza Vaccine Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Influenza Vaccine Business
14.1 AstraZeneca
14.1.1 AstraZeneca Company Profile
14.1.2 AstraZeneca Influenza Vaccine Product Specification
14.1.3 AstraZeneca Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 CSL
14.2.1 CSL Company Profile
14.2.2 CSL Influenza Vaccine Product Specification
14.2.3 CSL Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 GlaxoSmithKline
14.3.1 GlaxoSmithKline Company Profile
14.3.2 GlaxoSmithKline Influenza Vaccine Product Specification
14.3.3 GlaxoSmithKline Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Sanofi
14.4.1 Sanofi Company Profile
14.4.2 Sanofi Influenza Vaccine Product Specification
14.4.3 Sanofi Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 Altimmune
14.5.1 Altimmune Company Profile
14.5.2 Altimmune Influenza Vaccine Product Specification
14.5.3 Altimmune Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 BionVax
14.6.1 BionVax Company Profile
14.6.2 BionVax Influenza Vaccine Product Specification
14.6.3 BionVax Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 FluGen
14.7.1 FluGen Company Profile
14.7.2 FluGen Influenza Vaccine Product Specification
14.7.3 FluGen Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 FOLIA BIOTECH
14.8.1 FOLIA BIOTECH Company Profile
14.8.2 FOLIA BIOTECH Influenza Vaccine Product Specification
14.8.3 FOLIA BIOTECH Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Genentech
14.9.1 Genentech Company Profile
14.9.2 Genentech Influenza Vaccine Product Specification
14.9.3 Genentech Influenza Vaccine Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Influenza Vaccine Market Forecast (2022-2027)
15.1 Global Influenza Vaccine Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Influenza Vaccine Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Influenza Vaccine Value and Growth Rate Forecast (2022-2027)
15.2 Global Influenza Vaccine Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Influenza Vaccine Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Influenza Vaccine Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Influenza Vaccine Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Influenza Vaccine Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Influenza Vaccine Consumption Forecast by Type (2022-2027)
15.3.2 Global Influenza Vaccine Revenue Forecast by Type (2022-2027)
15.3.3 Global Influenza Vaccine Price Forecast by Type (2022-2027)
15.4 Global Influenza Vaccine Consumption Volume Forecast by Application (2022-2027)
15.5 Influenza Vaccine Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

2023-2028 Global and Regional Rapid Influenza Diagnostic Test (RIDT) Industry Status and Prospects Professional Market Research Report Standard Version...

The global Rapid Influenza Diagnostic Test (RIDT) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help mark...

2023-2028 Global and Regional Whole Cell Cholera Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Viral Vaccine Media Industry Status and Prospects Professional Market Research Report Standard Version...

The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...